Co-Diagnostics Inc <CODX.OQ> expected to post a loss of 33 cents a share - Earnings Preview

• Co-Diagnostics Inc CODX.OQ CODX.O is expected to show a fall in quarterly revenue when it reports results on May 8 for the period ending March 31 2025

• The Salt Lake City Utah-based company is expected to report a 19.8% decrease in revenue to $375 thousand from $467.85 thousand a year ago, according to the estimate from one analyst, based on LSEG data.

• ​LSEG's mean analyst estimate for Co-Diagnostics Inc is for a loss of 33 cents per share.

• The one available analyst rating on the shares is "hold".

• The mean earnings estimate of analysts was unchanged in the last three months. ​

• Wall Street's median 12-month price target for Co-Diagnostics Inc is $1.00​, above​ its last closing price of $0.35. ​​​

This summary was machine generated May 6 at 20:16 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)